Trial Profile
A single center, prospective study of vonoprazan, clarithromycin and amoxicillin based regimen patients with Helicobacter-pylori-infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Vonoprazan (Primary) ; Rabeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 14 Dec 2016 New trial record
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week.